BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9063015)

  • 1. Biological behaviour of moderate dysplasia--a prospective study.
    Murthy NS; Sardana S; Narang N; Agarwal SS; Sharma S; Das DK
    Indian J Cancer; 1996 Mar; 33(1):24-30. PubMed ID: 9063015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavior of moderate cervical dysplasia during long-term follow-up.
    Nasiell K; Nasiell M; Vaćlavinková V
    Obstet Gynecol; 1983 May; 61(5):609-14. PubMed ID: 6835614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the HSIL subclassification cytologically real and clinically justified?
    Milicić-Juhas V; Pajtler M
    Coll Antropol; 2010 Jun; 34(2):395-400. PubMed ID: 20698108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cervical dysplasia].
    Tabachnik BI; Nikitina MA
    Vopr Onkol; 1984; 30(3):21-8. PubMed ID: 6710945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conization for cervical dysplasia and carcinoma in situ: long term follow-up of 1013 women.
    Larsson G
    Ann Chir Gynaecol; 1981; 70(2):79-85. PubMed ID: 7316444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on the development of dysplasia.
    Heinzl S; Szalmay G; Jochum L; Roemer V
    Acta Cytol; 1982; 26(4):453-6. PubMed ID: 6957097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of precancerous and early cancerous lesions of the uterine cervix.
    Luthra UK; Prabhakar AK; Seth P; Agarwal SS; Murthy NS; Bhatnagar P; Das DK; Sharma BK
    Acta Cytol; 1987; 31(3):226-34. PubMed ID: 3035845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
    Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
    Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of 189 women diagnosed with uterine cervical dysplasia based on abnormal results in mass screening.
    Muramatsu T; Yoshitake T; Iida T; Yamashita E; Hirasawa T; Miyamoto T; Murakami M; Matsui N; Kajiwara H; Yasuda M; Osamura RY; Mikami M
    Tokai J Exp Clin Med; 2006 Dec; 31(4):141-5. PubMed ID: 21302243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of abnormal cervical cytology in a group of New Zealand women using contraception: a preliminary report. The New Zealand Contraception and Health Study Group.
    N Z Med J; 1989 Jul; 102(872):369-71. PubMed ID: 2797552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphotometric DNA analysis in mild and moderate dysplasia of the uterine cervix: a retrospective study.
    Kashyap V; Das DK; Luthra UK
    Indian J Pathol Microbiol; 1990 Jan; 33(1):30-4. PubMed ID: 2394473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The invasive potential of carcinoma in situ of the cervix.
    McIndoe WA; McLean MR; Jones RW; Mullins PR
    Obstet Gynecol; 1984 Oct; 64(4):451-8. PubMed ID: 6483293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-cytometric diagnosis of prospective malignancy in borderline lesions of the uterine cervix.
    Böcking A; Hilgarth M; Auffermann W; Hack-Werdier C; Fischer-Becker D; von Kalkreuth G
    Acta Cytol; 1986; 30(6):608-15. PubMed ID: 3466496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
    Khaled A; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atypical cervical cytology during pregnancy in the region of Baranja].
    Milojković M; Lederer B; Jarcov R; Pajtler M
    Jugosl Ginekol Perinatol; 1991; 31(3-4):99-101. PubMed ID: 1749286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors related to biological behaviour of precancerous lesions of the uterine cervix.
    Murthy NS; Sehgal A; Satyanarayana L; Das DK; Singh V; Das BC; Gupta MM; Mitra AB; Luthra UK
    Br J Cancer; 1990 May; 61(5):732-6. PubMed ID: 2337509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dysplasia and carcinoma in situ of the uterine cervix in pregnancy].
    Pajtler M; Cugalj B; Milojković M; Makarović Z
    Jugosl Ginekol Perinatol; 1990; 30(1-2):15-8. PubMed ID: 2214848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysplasia during pregnancy: a cytologic follow-up study.
    Kiguchi K; Bibbo M; Hasegawa T; Kurihara S; Tsutsui F; Wied GL
    J Reprod Med; 1981 Feb; 26(2):66-72. PubMed ID: 7012336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of HSV-2 antigen in carcinoma cervix and premalignant conditions by immuno-cytochemistry.
    Pandit AA; Khilnani PH; Powar H; Bhave GG; Chadda NO
    J Postgrad Med; 1990 Oct; 36(4):185-90. PubMed ID: 2132242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of prospective malignancy of cervix dysplasia using DNA cytometry].
    Bollmann R
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):113-7. PubMed ID: 2318402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.